Spontaneous pregnancy following intra-ovarian platelet-rich plasma administration in poor ovarian responders according to the POSEIDON criteria: A cross-sectional study

Marzie Sanuie Farimani, Sanuie Farimani M, Amiri K, Kimia Amiri, Anvari Aliabad R, Roghayeh Anvari Aliabad
International journal of reproductive biomedicine · 2025 · vol. 23(8) , pp. 627–636 · doi:10.18502/ijrm.v23i8.19811 · PMID:41306715 · PMC12477538
other OA: gold public-domain-us
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-25 ⓘ

This cross-sectional study of 596 poor ovarian responders found an 8.39% spontaneous pregnancy rate following intra-ovarian platelet-rich plasma administration, with significant biodemographic differences between those who conceived and those who did not.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-25 · read from full text ⓘ

This cross-sectional study examined the characteristics of 42 women with poor ovarian response who achieved spontaneous pregnancy after receiving intra-ovarian platelet-rich plasma injections. The researchers analyzed biodemographic and laboratory data, finding significant differences among POSEIDON groups regarding age, body mass index, anti-Müllerian hormone levels, and follicle counts. The authors noted that while group 4 was the most prevalent, this likely reflected population size rather than increased susceptibility to pregnancy following the treatment. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Female infertility, especially in those individuals with poor ovarian response (POR), is a challenge in the field of infertility and sterility. Recently, intra-ovarian platelet-rich plasma (IO-PRP) administration has been suggested as a possible co-treatment. OBJECTIVE: This study aimed to investigate the biodemographic characteristics of individuals who experienced spontaneous pregnancy following IO-PRP. MATERIALS AND METHODS: In this cross-sectional study, out of 1548 women diagnosed with POR who underwent IO-PRP, 596 individuals who completed their 2-yr follow-up period, were included. Different types of demographic and pre-intervention laboratory data (blood levels of anti-Müllerian hormone, luteinizing hormone, follicle-stimulating hormone, estradiol, prolactin, and their spouses' sperm analysis results) were collected from the files. Each individual was classified into a certain group according to the POSEIDON criteria, and their data were compared. RESULTS: The results showed that 50 (8.39%) spontaneous pregnancies were observed. However, 8 were excluded from further analyses due to missing data in their critical variables. The most prevalent POSEIDON group was 4, with a prevalence of 17/42 (40.47%). Among the POSEIDON groups, covariates including the age of the individuals and their spouses, body mass index, anti-Müllerian hormone, and antral follicle/oocytes count following the latest IO-PRP significantly differed (p < 0.001, p < 0.001, p = 0.039, p < 0.001, and p = 0.022, respectively). CONCLUSION: The spontaneous pregnancy rate following IO-PRP among women with POR was low. However, significant differences in biodemographic and hormonal characteristics were observed between the groups with and without spontaneous pregnancy which could be useful in leading future studies on this subject.
Full text 16,093 characters · extracted from pmc-nxml · 2 sections · click to expand

Section

M. Sanuie Farimani and R. Anvari Aliabad had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: M. Sanuie Farimani and R. Anvari Aliabad. Acquisition, analysis, or interpretation of data K. Amiri and R. Anvari Aliabad. Drafting of the manuscript: K. Amiri and R. Anvari Aliabad. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: K. Amiri. Supervision: M. Sanuie Farimani and R. Anvari Aliabad.

Coi Statement

The authors declare that there is no conflict of interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
pubmed
last seen: 2026-10-04T06:09:33.201670+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine